AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.

Clinical trial NCT05170737 · COMPLETED

Trial details

NCT number: NCT05170737
Sponsor: Aelis Farma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety, Tolerability, Pharmacokinetics of AEF0217

Start date: 2021-10-01
Primary completion: 2022-06-28
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.